Medical technology company Integer Holdings (NYSE:ITGR) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 8.4% year on year to $467.7 million. On the other hand, the company’s ...
Integer Holdings Corporation (NYSE:ITGR) recently acquired certain assets of US BioDesign — a company manufacturing complex braided biomedical structures for disposable and implantable medical devices ...
On Friday, Piper Sandler increased its price target for Integer Holdings (NYSE:NYSE:ITGR) shares to $140 from $125, while maintaining an Overweight rating on the stock. The adjustment follows the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results